검색어: rabbit haemorrhagic disease (영어 - 몰타어)

eravac rabbit haemorrhagic disease vaccine, inactivated
eravac vaċċin kontra l-marda emorraġika tal-fniek, inattivat

epizootic haemorrhagic disease (ehd)
marda emorraġika epiżootika

epizootic haemorrhagic disease of deer
il-marda epiżootika ta' l-emorraġija taċ-ċriev

bluetongue and epizootic haemorrhagic disease
bluetongue u l-marda epiżootika emorraġika

bluetongue and epizootic haemorrhagic disease (ehd)
bluetongue u l-marda epiżootika emorraġika (ehd).

to stimulate immunity against myxoma virus and rabbit haemorrhagic disease virus.
sabiex jistimula l-immunità kontra l-virus myxoma u l-marda virali emorraġika tal-fniek.

after vaccination the rabbits were artificially infected with rabbit haemorrhagic disease type 2 virus.
wara t-tilqima l-fniek kienu infettati artifiċjalment bil-virus tal-marda emorraġika tal-fniek tat-tip 2.

to stimulate active immunity against the rabbit haemorrhagic disease type 2 virus (rhdv2).
biex tistimola l-immunità attiva kontra l-mard emorraġiku tal-fniek virus tat-tip 2 (rhdv2).

the vaccine strain is a myxoma virus expressing the capsid protein gene of rabbit haemorrhagic disease virus.
l-istrejn tal-vaċċin huwa myxomatosis li juri l-ġene tal-proteina capsid tal-virus tal-marda emorraġika tal-fniek.

inactivated rabbit haemorrhagic disease type 2 virus (rhdv2), strain v-1037 ≥70% celisa40
mard emorraġiku tal-fniek virus tat-tip 2 (rhdv2) mhux attivat. razza v-1037 ≥70% celisa40

eravac contains inactivated rabbit haemorrhagic disease type 2 virus, strain (v-1037), as the active substance.
eravac fih il-virus tal-marda emorraġika tal-fniek tat-tip 2 inattivat, razza (v-1037), bħala s-sustanza attiva.

in the future if rabbits are exposed to rabbit haemorrhagic disease type 2 virus, the immune system will be able to produce antibodies more quickly.
fil-futur jekk il-fniek ikunu esposti għall-virus tal-marda emorraġika tal-fniek tat-tip 2, is-sistema immunitarja tkun kapaċi tipproduċi antikorpi aktar malajr.

for active immunisation of fattening rabbits from the age of 30 days to reduce mortality caused by the rabbit haemorrhagic disease type 2 virus (rhdv2).
għal immunizzazzjoni attiva ta’ fniek għas-sinna minn 30 jum biex tnaqqas l-mortalità kkawżata minn mard emorraġiku tal-fniek virus tat-tip 2 (rhdv2).

european foulbrood varroasis and acariasis apes and felids tuberculosis ruminants tuberculosis lagomorphs myxomatosis viral haemorrhagic disease tularaemia
mink naħal xadini u felidi ruminanti lagomorfi enterite virali mard alewzjan foulbrood ewropew varroasus u acariasis tuberkolożi tuberkolożi myxomatosis mard emoraġiku virali tularaemia

whereas in accordance with the opinion of the scientific veterinary committee, an additional test for epizootic haemorrhagic disease is required;
billi bi qbil ma' l-opinjoni tal-kumitat xjentifiku veterinarju, test addizzjonali għal marda ta' l-emoroloġija epiżotika huwa meħtieġ;

for active immunisation of rabbits to reduce mortality and clinical signs of myxomatosis and to prevent mortality due to rabbit haemorrhagic disease (rhd) caused by classical rhd virus strains.
għall-immunità attiva tal-fniek ta’ età minn 5 ġimgħat ’il fuq biex inaqqas l-imwiet u sintomi kliniċi tal-myxomatosis u biex jipprevjeni l-imwiet miħabba l-marda emorraġika tal-fniek (rhd) ikkawżat mill-strejn virali rhd klassiku.

rabbits that have been vaccinated previously with another myxomatosis vaccine, or that have experienced natural myxomatosis infection in the field, may not develop a proper immune response against rabbit haemorrhagic disease following vaccination.
fniek li kienu mlaqqma qabel b’vaċċin ieħor tal-myxomatosis, jew li esperjenzaw infezzjoni natural tal- myxomatosis, jistgħu ma jiżviluppawx rispons immunitarju tajjeb għall-marda emorraġika tal-fniek wara l-vaċċinazzjoni.

either [ii.2.6.1. which according to official findings is free from epizootic haemorrhagic disease (ehd);]
jew [ii.2.6.1. li skont is-sejbiet uffiċjali huma ħielsa minn mard epiżootiku tal-emorraġija (ehd);]

for active immunisation of rabbits from 5 weeks of age onwards to reduce mortality and clinical signs of myxomatosis and to prevent mortality due to rabbit haemorrhagic disease (rhd) caused by classical rhd virus strains.
għall-immunità attiva tal-fniek ta’ età minn 5 ġimgħat ’il fuq biex inaqqas l-imwiet u sintomi kliniċi tal-myxomatosis u biex jipprevjeni l-imwiet minħabba l-marda emorraġika tal-fniek (rhd) ikkawżat mill-strejn virali rhd klassiku.

in and around which in an area of radius of 150 km, there has been no case/outbreak of bluetongue and epizootic haemorrhagic disease during the previous 60 days, and
fejn fih u madwaru, f’żona b’raġġ ta’ 150 km, ma kien hemm l-ebda każ/tfaqqigħ ta’ bluetongue u tal-marda epiżootika emorraġika matul is-60 jum ta’ qabel, u